Literature DB >> 31084759

Magnetic resonance cholangiopancreatography at 3 Tesla: Image quality comparison between 3D compressed sensing and 2D single-shot acquisitions.

Fabian K Lohöfer1, Georgios A Kaissis1, Michael Rasper1, Christoph Katemann2, Andreas Hock2, Johannes M Peeters3, Christoph Schlag4, Ernst J Rummeny1, Dimitrios Karampinos1, Rickmer F Braren5.   

Abstract

OBJECTIVES: To compare the image quality between compressed sensing (CS) 3D-magnetic resonance cholangiopancreatography (MRCP) using respiratory-triggered (RT) and breath-hold (BH) acquisitions and 2D single-shot breath-hold (SSBH) MRCP at 3 T MRI.
METHODS: 53 datasets were retrospectively assessed. 3D-MRCP with CS (RT-CS10, BH-CS24) and 2D-SSBH MRCP were acquired. Overall image quality, blurring/motion artifacts and discernibility of the pancreaticobiliary tree (PBT) structures were scored on a 4-point scale by 2 radiologists. The contrast ratio between the common bile duct and its adjacent tissue was measured by region-of-interest (ROI) analysis. Signal intensity increase at the boundaries of the ducts was quantified by line profiles to objectively characterize blurring and motion artifacts.
RESULTS: Total scan duration was 17 s for BH-CS24, 1m12 s for 2D-SSBH and 3m48 s for RT-CS10. Images acquired with CS were consistently rated superior in terms of image quality, background suppression, blurring and discernibility of PBT structures compared to 2D-SSBH images. RT-CS10 was superior to BH-CS24 for all ratings except for blurring. Objective analysis yielded the highest contrast ratio for RT-CS10 (0.91 ± 0.04) followed by BH-C24 (0.88 ± 0.05) and 2D-SSBH (0.85 ± 0.06); one-way ANOVA P < 0.0001. The line-profile slope through the CBD was significantly higher in BH-CS24 (37.91 ± 6.38% of maximum intensity/mm) compared to RT-CS10 (29.46 ± 8.17% of maximum intensity/mm) and on par with 2D-SSBH (35.8 ± 12.30% of maximum intensity/mm); one-way-ANOVA P = 0.017.
CONCLUSION: CS allows acquisition of volumetric image data with improved image quality compared to SSBH. CS24 yields substantial gains in acquisition speed while robust towards artifacts, enabling diagnostic image quality with a single breath-hold acquisition.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biliary tract; Diagnostic techniques and procedures; Magnetic resonance cholangiopancreatography; Magnetic resonance imaging; Pancreatic ducts

Mesh:

Year:  2019        PMID: 31084759     DOI: 10.1016/j.ejrad.2019.04.002

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

1.  Acceleration of pCASL-Based Cerebral 4D MR Angiography Using Compressed SENSE: A Comparison With SENSE.

Authors:  Maoxue Wang; Yiming Ma; Fei Chen; Fei Zhou; Jilei Zhang; Bing Zhang
Journal:  Front Neurol       Date:  2022-03-21       Impact factor: 4.003

2.  Magnetic resonance cholangiopancreatography at 3T in a single breath-hold: comparative effectiveness between three-dimensional (3D) gradient- and spin-echo and two-dimensional (2D) thick-slab fast spin-echo acquisitions.

Authors:  Cheng-Ping Chien; Feng-Mao Chiu; Yen-Chun Shen; Yi-Hsun Chen; Hsiao-Wen Chung
Journal:  Quant Imaging Med Surg       Date:  2020-06

3.  Clinical feasibility of ultrafast intracranial vessel imaging with non-Cartesian spiral 3D time-of-flight MR angiography at 1.5T: An intra-individual comparison study.

Authors:  Thomas Sartoretti; Elisabeth Sartoretti; Árpád Schwenk; Luuk van Smoorenburg; Manoj Mannil; André Euler; Anton S Becker; Alex Alfieri; Arash Najafi; Christoph A Binkert; Michael Wyss; Sabine Sartoretti-Schefer
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

4.  Balanced steady-state free precession MRCP is a robust alternative to respiration-navigated 3D turbo-spin-echo MRCP.

Authors:  Felix Christian Hasse; Buket Selmi; Hamed Albusaidi; Theresa Mokry; Philipp Mayer; Christian Rupp; Hans-Ulrich Kauczor; Tim Frederik Weber
Journal:  BMC Med Imaging       Date:  2021-01-11       Impact factor: 1.930

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.